Enzymes and Catalysis Explained
Every second, trillions of chemical reactions keep your cells alive — breaking down food, copying DNA, firing nerves, building proteins. These reactions would proceed far too slowly at body temperature without biological catalysts called enzymes. Understanding how enzymes work explains not only biology but also medicine, nutrition, and the biotechnology industry.
What Is a Catalyst?
A catalyst is a substance that speeds up a chemical reaction without being consumed in the process. It does this by providing an alternative reaction pathway with a lower activation energy — the minimum energy that reacting molecules must have to break existing bonds and form new ones.
Imagine a ball trying to roll over a hill: without the catalyst, the hill is high and few balls have enough energy to get over. A catalyst effectively lowers the height of the hill, so many more balls can cross per unit of time. The reaction products are unchanged — the catalyst only changes how quickly the hill is crossed, not the destination on the other side.
Inorganic catalysts (such as platinum in catalytic converters, or iron in the Haber process for making ammonia) work at high temperatures and pressures. Biological systems need a different kind of catalyst: one that works at body temperature (around 37°C), in watery conditions, and with extraordinary precision.
Enzymes: Biological Catalysts
Enzymes are globular proteins — their polypeptide chains are folded into a precise three-dimensional shape. This shape is maintained by hydrogen bonds, ionic interactions, disulfide bridges, and hydrophobic forces between the amino acid side chains (R groups). The exact sequence of amino acids, coded for in DNA, determines the folded shape, which in turn determines the enzyme's function.
Each enzyme is highly specific: it catalyses only one reaction or one type of reaction. This specificity arises from a precisely shaped region on the enzyme's surface called the active site.
The Active Site and the Lock-and-Key Model
The active site is a cleft or pocket in the enzyme's surface whose shape, charge distribution, and chemical properties are complementary to a specific molecule or pair of molecules called the substrate. The substrate fits into the active site as a key fits a lock — this is the lock-and-key model, proposed by Emil Fischer in 1894.
When the substrate binds to the active site, it forms an enzyme-substrate complex. Within this complex, the active site positions the substrate in exactly the right orientation and may provide acidic or basic amino acid side chains that directly participate in bond breaking and forming. The products of the reaction are released from the active site, which is then free to accept another substrate molecule. Because the enzyme is regenerated, a single enzyme molecule can catalyse thousands of reactions per second.
The Induced Fit Model
The lock-and-key model treats the active site as rigid and pre-formed. The induced fit model, proposed by Daniel Koshland in 1958 and now better supported by evidence, modifies this: the active site is flexible and changes shape as the substrate binds. The substrate does not fit a pre-existing lock; instead, both the enzyme and the substrate adjust their conformations to achieve an optimal fit.
This subtle distinction has important implications. It explains how some enzymes can accept structurally similar substrates (the flexible site accommodates slight variations), and it explains how enzyme inhibitors and activators can alter enzyme activity by changing the active site's shape even when bound elsewhere on the enzyme. The induced fit model is the currently accepted description of enzyme-substrate interaction.
Factors Affecting Enzyme Activity
Temperature affects enzyme activity in two opposing ways. As temperature rises from low to the optimum, molecules move faster, collisions between enzyme and substrate are more frequent, and reaction rate increases. Beyond the optimum temperature, however, the extra thermal energy begins to break the relatively weak hydrogen bonds and ionic interactions that maintain the enzyme's three-dimensional shape. The enzyme denatures: its active site changes shape, the substrate can no longer bind, and activity falls sharply. Denaturation is usually irreversible. Most human enzymes have an optimum around 37°C; enzymes from thermophilic bacteria that live in hot springs may have optima above 70°C.
pH affects the ionisation of the amino acid side chains in the active site. A change in pH alters the charges on these groups, which changes the active site's shape and its ability to bind the substrate. Each enzyme has a characteristic optimum pH at which activity is maximal: pepsin (a stomach protease) works best at around pH 2; salivary amylase (which begins starch digestion in the mouth) works best at around pH 7; trypsin (a pancreatic protease) works best at around pH 8. Extremes of pH denature enzymes by disrupting the ionic bonds and hydrogen bonds that maintain their structure.
Substrate concentration affects rate up to a point. At low substrate concentrations, many active sites are empty and rate is limited by how often substrate molecules arrive. As concentration rises, more active sites are occupied and rate increases. Eventually all active sites are simultaneously occupied — the enzyme is saturated — and adding more substrate produces no further increase in rate. This maximum rate is called Vmax. The concentration of substrate at which the reaction rate is half Vmax is called the Michaelis constant (Km): a lower Km means the enzyme has a higher affinity for its substrate.
Enzyme concentration affects rate similarly: if substrate is in excess, increasing the number of enzyme molecules increases the rate (more active sites available). Once all substrate molecules are bound to enzymes, adding more enzyme has no effect.
Competitive inhibitors have a shape similar to the substrate. They bind to the active site and block the substrate from entering. The inhibitor and substrate compete for the same site. This type of inhibition can be overcome by increasing the substrate concentration — with enough substrate molecules present, the active sites tend to be occupied by substrate rather than inhibitor. Non-competitive inhibitors bind to a different region of the enzyme (an allosteric site) and change the enzyme's overall shape so that the active site no longer fits the substrate efficiently. Because the inhibitor does not compete for the active site, increasing substrate concentration does not reverse the inhibition. Many pharmaceutical drugs work as competitive inhibitors: statins (used to lower cholesterol) competitively inhibit an enzyme in the cholesterol synthesis pathway; some antibiotics inhibit bacterial enzymes critical for cell wall synthesis.
Cofactors and Coenzymes
Many enzymes require additional non-protein components to function. These are called cofactors. Inorganic cofactors are often metal ions: zinc is required by carbonic anhydrase (which converts carbon dioxide to carbonic acid in red blood cells); iron is part of the active site of cytochrome enzymes in the electron transport chain; magnesium is needed by many enzymes that use ATP.
Coenzymes are organic (carbon-containing) cofactors, often derived from vitamins. NAD+ and FAD, derived from niacin and riboflavin respectively, act as electron carriers in cellular respiration — they are not consumed but cycle between oxidised and reduced forms. Coenzyme A, derived from pantothenic acid, carries acetyl groups in metabolism. This is why vitamin deficiencies produce specific metabolic disorders: without the vitamin, the coenzyme cannot be made, and the enzyme that depends on it cannot function.
Enzymes in Industry and Medicine
Enzymes are used extensively outside the body. Proteases and lipases in biological washing powders digest protein and fat stains at relatively low temperatures. Lactase is added to dairy products to break down lactose for people who are lactose intolerant. Amylases convert starch to sugar in the production of beer and high-fructose corn syrup. Pectinases are used in juice production to break down cell walls and clarify the liquid.
In medicine, enzyme deficiency is the cause of many genetic diseases. Phenylketonuria (PKU) results from a deficiency of phenylalanine hydroxylase; without it, phenylalanine accumulates to toxic levels in the brain. Tay-Sachs disease results from a deficiency of a lysosomal enzyme that breaks down a specific lipid; the lipid accumulates in nerve cells with fatal consequences. Enzyme replacement therapy — providing the missing enzyme from an external source — is used in some of these conditions.
Summary
Enzymes are globular protein catalysts that lower the activation energy of biological reactions without being consumed. Each enzyme's active site is specific to its substrate; the induced fit model describes how both enzyme and substrate change conformation on binding to form the enzyme-substrate complex. Temperature increases rate to an optimum, then denatures the enzyme; pH has an optimum specific to each enzyme; rate is limited at high substrate concentration by saturation (Vmax). Competitive inhibitors block the active site; non-competitive inhibitors alter the enzyme's shape at an allosteric site. Cofactors and coenzymes are required by many enzymes and explain the metabolic role of vitamins. Enzyme technology is central to food production, medicine, and biotechnology.